Mustang Bio Announces Participation in Upcoming Scientific Meetings itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.
Bayer subsidiary BlueRock has become the first company to report initial success treating Parkinson's disease in humans using an experimental stem cell therapy, the drugmaker said on Wednesday. The hunt for Parkinson's treatments has seen many setbacks over decades. Bayer said that one year into a Phase I trial with 12 volunteers, BlueRock's therapy was shown to be well-tolerated and that transplanted cells grew as intended in patients' brains.
/PRNewswire/ EXUMA Biotech, Corp., a clinical-stage biotechnology company discovering and developing cell and gene therapies for liquid and solid tumors,.
Daewoong Pharmaceutical und Hanall Biopharma investieren 1 Mio USD in Alloplex Biotherapeutics finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.